Novasep Revenue and Competitors
Estimated Revenue & Valuation
- Novasep's estimated annual revenue is currently $300M per year.
- Novasep's estimated revenue per employee is $455,235
Employee Data
- Novasep has 659 Employees.
- Novasep grew their employee count by -17% last year.
Novasep's People
Name | Title | Email/Phone |
---|---|---|
1 | CEO & Chairman | Reveal Email/Phone |
2 | Head Manufacturing Science and Technology | Reveal Email/Phone |
3 | VP Business Development | Reveal Email/Phone |
4 | Chief Legal Officer | Reveal Email/Phone |
5 | Human Resources & Communication Director | Reveal Email/Phone |
6 | Chief Financial Officer | Reveal Email/Phone |
7 | Director | Reveal Email/Phone |
8 | Project Management Officer | Reveal Email/Phone |
9 | HR & Site Administration Manager | Reveal Email/Phone |
10 | Project Manager | Reveal Email/Phone |
Novasep Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $7.5M | 18 | 0% | N/A | N/A |
#2 | $1700M | 3615 | 3% | N/A | N/A |
#3 | $7.5M | 71 | 0% | N/A | N/A |
#4 | $1180M | 257 | 15% | N/A | N/A |
#5 | $3.5M | 46 | 7% | N/A | N/A |
#6 | $7.5M | 51 | -19% | N/A | N/A |
#7 | $7.5M | 12 | -20% | N/A | N/A |
#8 | N/A | 27 | 4% | N/A | N/A |
#9 | $7.5M | 33 | 0% | N/A | N/A |
#10 | N/A | 9 | 0% | N/A | N/A |
What Is Novasep?
Novasep serves Life Sciences industries, such as human health, animal health, cosmetics, food additives, agrochemicals. Novasep designs purification processes aimed at producing a variety of biomolecules like: Vaccines and vitamins Proteins and enzymes Peptides and antibiotics Milk proteins and amino acid derivatives Sweeteners of various types The synthesis of organic molecules, either advanced intermediates or APIs (Active Pharlaceutical Ingredients) is often carried out by integrating the purification technologies mastered by the group. This combination that impoves synthetic pathways of molecules is used every day to develop and produce our customers' innovative drugs. Current applications are found with drugs that treat: Cancer Cardiovascular disorders, i.e. high blood pressure
keywords:N/AN/A
Total Funding
659
Number of Employees
$300M
Revenue (est)
-17%
Employee Growth %
N/A
Valuation
N/A
Accelerator
Novasep News
In addition, the acquisition of the chromatography business of Novasep further strengthened our positioning in downstream processing.
Novasep, Brammer Bio, Lonza, Cobra Biologics, Oxford Biomedica, Finvector Vision Therapies, Merck KGaA, Spark Therapeutics, uniQure, Merck.
Michel Spagnol, the former CEO of Novasep, will join the new company's board of directors. He said, I have great confidence that the group...